May 2, 2011

Watson Pharmaceuticals has launched an authorized generic version of a Johnson & Johnson drug for treating attention deficit hyperactivity disorder through a subsidiary, Watson said Monday.

April 11, 2011

The Food and Drug Administration has approved a drug made by Johnson & Johnson for treating schizophrenia in adolescents.

November 1, 2010

Generic drug maker Watson Pharmaceuticals will distribute an authorized generic version of a drug used...

June 21, 2010

Metabolex has entered an agreement to discover and develop Type 2 diabetes drugs with a...

May 23, 2010

Two subsidiaries of Johnson & Johnson will pay more than $81 million to the federal...